Cumberland Pharmaceuticals (CPIX) Total Debt: 2009-2025
Historic Total Debt for Cumberland Pharmaceuticals (CPIX) over the last 16 years, with Sep 2025 value amounting to $5.2 million.
- Cumberland Pharmaceuticals' Total Debt fell 67.43% to $5.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $31.0 million, marking a year-over-year decrease of 49.23%. This contributed to the annual value of $15.3 million for FY2024, which is 19.49% up from last year.
- Cumberland Pharmaceuticals' Total Debt amounted to $5.2 million in Q3 2025, which was down 0.00% from $5.2 million recorded in Q2 2025.
- In the past 5 years, Cumberland Pharmaceuticals' Total Debt registered a high of $20.0 million during Q1 2022, and its lowest value of $5.2 million during Q1 2025.
- Over the past 3 years, Cumberland Pharmaceuticals' median Total Debt value was $13.1 million (recorded in 2023), while the average stood at $12.2 million.
- In the last 5 years, Cumberland Pharmaceuticals' Total Debt surged by 35.71% in 2022 and then slumped by 67.43% in 2025.
- Cumberland Pharmaceuticals' Total Debt (Quarterly) stood at $15.0 million in 2021, then increased by 8.00% to $16.2 million in 2022, then declined by 21.09% to $12.8 million in 2023, then rose by 19.49% to $15.3 million in 2024, then slumped by 67.43% to $5.2 million in 2025.
- Its Total Debt was $5.2 million in Q3 2025, compared to $5.2 million in Q2 2025 and $5.2 million in Q1 2025.